Imagine a watch or slim band on your wrist quietly reading your blood pressure while you sleep, cook dinner, or finish a run — no squeezing, no inflatable cuff, no holding still. That’s what a cuffless blood pressure monitor does, and it represents a genuine shift in how we think about cardiovascular tracking. Traditional arm cuffs give you one number at one moment — often in a doctor’s office, which introduces a real problem. White coat hypertension affects between 15 and 30 percent of patients, producing falsely elevated readings in clinical settings and sending millions home with an inaccurate picture of their heart health. Even for everyone else, a once-a-week spot check misses how blood pressure actually moves through daily life.
These devices estimate blood pressure continuously using PPG light sensors, ECG signals, or bioimpedance — capturing data during workouts, rest, and sleep. The Aktiia Hilo Band is among the first FDA-cleared cuffless monitors in the US, validated to the ISO-81060-2 standard used for traditional cuffs, though monthly calibration against a cuff is still required. Samsung Galaxy Watch 7 offers on-demand readings after calibration, not continuous monitoring, and has regional availability limits. Whoop 5.0 MG delivers blood pressure trends rather than absolute numbers, at a high subscription cost. AI is genuinely helping narrow the accuracy gap across all these platforms.
Still, a 2026 JAMA Cardiology expert review found most cuffless devices have not undergone standardized clinical validation. Cardiologist Dr. Eugene Yang was direct: “Accuracy — with risk of undertreatment or overtreatment — remains a key concern… we should not rely on data from unvalidated devices.” Nearly half of US adults have high blood pressure, many unaware between visits. Trend tracking with a wearable is genuinely useful. Replacing your arm cuff for diagnosis or medication decisions is not yet.
[Read the full expert review here →] [FULL ARTICLE LINK]
